A detailed history of Howard Financial Services, Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, Howard Financial Services, Ltd. holds 4,240 shares of AZN stock, worth $284,843. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,240
Previous 4,240 -0.0%
Holding current value
$284,843
Previous $330,000 -0.0%
% of portfolio
0.05%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$61.03 - $69.57 $243,753 - $277,862
-3,994 Reduced 48.51%
4,240 $287,000
Q3 2023

Oct 10, 2023

BUY
$64.85 - $71.7 $3,696 - $4,086
57 Added 0.7%
8,234 $557,000
Q1 2023

Apr 05, 2023

BUY
$63.15 - $71.6 $7,262 - $8,234
115 Added 1.43%
8,177 $567,000
Q3 2022

Oct 12, 2022

BUY
$53.02 - $135.75 $3,287 - $8,416
62 Added 0.78%
8,062 $442,000
Q2 2022

Jul 18, 2022

BUY
$59.26 - $71.14 $474,080 - $569,120
8,000 New
8,000 $529,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Howard Financial Services, Ltd. Portfolio

Follow Howard Financial Services, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howard Financial Services, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Howard Financial Services, Ltd. with notifications on news.